Editorial: Rising stars in inflammation 2021

A Baragetti; J Suurmond; P E Marques; L P Tavares

doi:10.3389/fimmu.2023.1193694

Editorial: Rising stars in inflammation 2021

Front Immunol. 2023 May 3:14:1193694. doi: 10.3389/fimmu.2023.1193694. eCollection 2023.

Authors

A Baragetti¹, J Suurmond², P E Marques³, L P Tavares⁴

Affiliations

¹ Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", University of Milan, Milan, Italy.
² Department of Rheumatology, Leiden University Medical Center (LUMC), Leiden, Netherlands.
³ Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
⁴ Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.

No abstract available

Keywords: adaptive immunity; cellular reprogramming; chronic pathologies; inflammation; innate immunity.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunity, Innate*
Inflammation*

Grants and funding

Author AB received the following funding: “Cibo, Microbiota, Salute” by “Vini di Batasiolo S.p.A” AL_RIC19ABARA_01; a research award (2021) from “the Peanut Institute”; Ministry of Health—Ricerca Corrente—IRCCS MultiMedica; PRIN 2017H5F943; ERANET ER- 2017-2364981; “PNRR M4C2-Investimento 1.4-CN00000041”, European Union—NextGeneration EU. Author PEM received the following funding: the Research Foundation of Flanders (FWO-Vlaanderen; G058421N and G025923N) and a Marie Sklodowska-Curie Fellowship (MSCA-IF-2018-839632). The funder agencies for both these authors were not involved in the interpretation of data and the manuscripts reviewed in this Editorial, nor participated in any form in writing this article and in the decision to submit it for publication.